Search filters
Launch of TerugBetaalRegeling Broxil®

Launch of TerugBetaalRegeling Broxil®

30/07/2020

The health insurer does not fully reimburse Broxil® 125 mg / 5 mL, powder for oral suspension. The producer of this medicine has...

Launch of TerugBetaalRegeling Acecort® en Fludrace®Launch of TerugBetaalRegeling Acecort® en Fludrace®

Launch of TerugBetaalRegeling Acecort® en Fludrace®

01/06/2020

The health insurer does not fully reimburse Acecort® 1mg and Fludrace® 62.5mcg. The producer of this medicine has therefore asked...

Termination TerugBetaalRegeling Xarelto®

Termination TerugBetaalRegeling Xarelto®

24/12/2019

Xarelto® is fully reimbursement from the 1st of January 2020. For this reason the co-payment is ended. Expenses from before the...

Termination TerugBetaalRegeling Invega®

Termination TerugBetaalRegeling Invega®

02/12/2019

Invega® is fully reimbursement from the 1st of December 2019. For this reason the co-payment is ended. Expenses from before the...

Specified overview health insurer

Specified overview health insurer

28/11/2019

To consider and process an invoice of a GVS medicine, we need a specified overview of your healthcare costs issued by your health...

Select your medicine

Check your medicine expenses

Quickly check the maximum contribution you have to pay for your medicine

Check Medicijnkosten

You are currently offline. Some pages or content may fail to load.